Diseases, Conditions, Syndromes

Researchers use mobile device data to predict COVID-19 outbreaks

Researchers at the Yale School of Public Health were able to accurately predict outbreaks of COVID-19 in Connecticut municipalities using anonymous location information from mobile devices, according to a new study published ...

Diseases, Conditions, Syndromes

Researcher develops town-level model for COVID-19 in Connecticut

UConn professor of geography Peter Chen has published a study in the January 2021 issue of the International Journal of Geographical Information Science outlining a comprehensive predictive model for COVID-19 in every Connecticut ...

Diseases, Conditions, Syndromes

The secret of Connecticut's success in battling COVID-19

On June 30, 21,416 COVID-19 tests were performed in the state of Connecticut. Only 152 came back positive. This represented a remarkable turnaround for a state that regularly saw more than 1,000 new cases a day in April. ...

Medications

In Connecticut, drug overdoses doubled in six years

Opioid overdose deaths in Connecticut doubled in the past six years, largely driven by use of multiple drugs together, according to a team of researchers from the University of Connecticut and Yale University.

Medications

Video: Fighting the opioid epidemic with data

In an effort to stay a step ahead of the opioid epidemic, UConn Health is part of a collaboration with the state Department of Public Health (DPH) that aims to track crucial data and create an early warning system to alert ...

Health

Court: Yes, there is doctor-patient confidentiality

Connecticut's highest court has ruled on an issue that most people may think is already settled, saying doctors have a duty to keep patients' medical records confidential and can be sued if they don't.

Medications

States seek to expand lawsuit against generic drug-makers

Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drug-makers to include more manufacturers and medications, as well as senior executives at two companies.

page 2 from 4